Merck stock (NYSE: MRK) lost about 10% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year.

The global Veterinary Vaccines Market, valued at US$8.93 billion in 2023, is forecasted to grow at a robust CAGR of 6.1%, reaching US$9.39 billion ...

Magnificent Seven stocks. Big Tech's runaway growth created gains, but headwinds are forming and some observers doubt the Mag ...

Hill’s Pet Nutrition is sponsoring the VMX Sunday Spectacular so join them in the Expo Hall at the VMX Main Stage from 7:30 to 9:30 PM Sunday, January 26, 2025, to see Acrobatic Art with HeART, a ...

Key players in this space, including the above-mentioned Shuttle Pharmaceuticals, Northwest Biotherapeutics, alongside majors such as %Merck (NYSE ... as well as a PET diagnostic reagent and as a ...

Merck did not immediately reply to Bloomberg’s e-mailed request for comments. Chinese pet owner’s use of human Covid-19 drugs on animals is in stark contrast to the early days of the pandemic ...

Merck & Co's Covid-19 antivirals are getting ... along with money on expensive veterinary bills. "Covid-19 drugs for humans saved my cat's life," one user wrote on Xiaohongshu.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The winners of this year's awards represent the best in 2024 of advertising, public relations, digital, video, social, design ...

and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. Merck has ...